Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | Know Labs Provides Overview of FY2024 10-K Annual Report | 32 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its... ► Artikel lesen | |
Fr | Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results | 74 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and... ► Artikel lesen | |
14.11. | KNOW LABS, INC. - 10-K, Annual Report | - | SEC Filings | ||
30.10. | Know Labs expands stock authorization and equity plan | 1 | Investing.com | ||
30.10. | KNOW LABS, INC. - 8-K, Current Report | - | SEC Filings | ||
28.10. | Know Labs extends debt maturity, raises interest rate | 1 | Investing.com | ||
11.10. | Know Labs-Aktie erreicht 52-Wochen-Tief bei 0,23 US-Dollar | 1 | Investing.com Deutsch | ||
KNOW LABS Aktie jetzt für 0€ handeln | |||||
02.10. | Know Labs faces NYSE American non-compliance notice | 2 | Investing.com | ||
02.10. | Know Labs erhält Non-Compliance-Mitteilung der NYSE American | 3 | Investing.com Deutsch | ||
02.10. | Know Labs announces notification of noncompliance with NYSE American continued listing standards | 1 | Seeking Alpha | ||
02.10. | Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards | 62 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the "Company" or "Know Labs"), a leading developer of non-invasive diagnostics technology, announced today that it received a notice... ► Artikel lesen | |
27.09. | Know Labs bestätigt Wirtschaftsprüfer und Vorstandswahlen | 1 | Investing.com Deutsch | ||
27.09. | Know Labs ratifies auditor and board elections | 1 | Investing.com | ||
27.09. | KNOW LABS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
11.09. | Know Labs Director steps down, audit committee sees new appointment | 1 | Investing.com | ||
11.09. | KNOW LABS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
16.08. | Know Labs stock falls as it looks to raise $1.66M | 1 | Seeking Alpha | ||
15.08. | Earnings call: Know Labs reports Q3 financials and development progress | 1 | Investing.com | ||
14.08. | Know Labs, Inc. Reports Third Quarter FY 2024 Results | 107 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter of the... ► Artikel lesen | |
14.08. | KNOW LABS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 32,860 | +2,02 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 44 auf 42 Euro gesenkt, aber die Einstufung auf "Buy" belassen. "Nächster Schritt: Revitalisierung",... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
GERRESHEIMER | 69,15 | -1,43 % | Aixtron, Gerresheimer, Hugo Boss, K+S, Lufthansa, Rheinmetall u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
CARL ZEISS MEDITEC | 54,90 | -3,51 % | Carl Zeiss Meditec Aktie: Planänderungen erforderlich | Die Carl Zeiss Meditec-Aktie verzeichnete am Handelstag einen deutlichen Kursrückgang. Im XETRA-Handel fiel der Aktienkurs um 2,3 Prozent auf 56,65 Euro, nachdem er bei Börseneröffnung noch bei 58,65... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 49,280 | -0,85 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers nach einer Investorenveranstaltung mit einem Kursziel von 65,90 Euro auf "Overweight" belassen. Die Themen... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 20,790 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,610 | +1,99 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für FMC von 37 auf 41 Euro angehoben und die Einstufung auf "Halten" belassen. Der Dialyseanbieter habe ein gelungenes Quartal hinter sich... ► Artikel lesen | |
GENEDX | 69,40 | 0,00 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
TEMPUS AI | 58,12 | 0,00 % | Cathie Wood's ARK ETFs Adjust Portfolio with Notable Tesla and Tempus AI Stock Trades | ||
NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 11,980 | 0,00 % | Alignment Healthcare announces offering of $330M convertible debt | ||
PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
ENDRA LIFE SCIENCES | 5,070 | 0,00 % | ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update | ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months... ► Artikel lesen | |
RXSIGHT | 44,830 | 0,00 % | Rxsight Co-Präsident Ilya Goldshleger verkauft Aktien im Wert von 363.752 US-Dollar |